< Terug naar vorige pagina
Onderzoeker
Kevin Punie
- Disciplines:Laboratoriumgeneeskunde, Palliatieve zorg en zorg rond het levenseinde, Regeneratieve geneeskunde, Andere basiswetenschappen, Andere gezondheidswetenschappen, Verpleegkunde, Andere paramedische wetenschappen, Andere translationele wetenschappen, Andere medische en gezondheidswetenschappen
Affiliaties
- Laboratorium Experimentele Oncologie (Afdeling)
Lid
Vanaf28 feb 2017 → Heden
Projecten
1 - 2 of 2
- Nieuwe biomerkers in de risicostratificatie, opvolging en behandeling van jonge patiënten met borstkankers en dragers van kiembaan pathogene varianten in TP53.Vanaf1 sep 2020 → 13 feb 2023Financiering: Eigen Middelen zoals patrimonium, inschrijvingsgelden, giften, ....
- Terugval in borst- en gynaecologische kankers.Vanaf1 feb 2019 → 1 okt 2021Financiering: Privé-financiering van binnenlandse oorsprong - onbepaald
Publicaties
11 - 20 van 75
- Preventing taxane-related peripheral neuropathy, pain and nail toxicity: a prospective self-controlled trial comparing hilotherapy with frozen gloves in early breast cancer(2022)
Auteurs: Annemarie Coolbrandt, Hilde Peeters, Annouschka Laenen, Patrick Neven, Kevin Punie, Hans Wildiers
Pagina's: 293 - 301 - Adding a platinum agent to neoadjuvant chemotherapy for triple-negative breast cancer: the end of the debate(2022)
Auteurs: Kevin Punie
Pagina's: 347 - 349 - Assessment of health-related quality of life by clinical response from the phase 3 ASCENT study in metastatic triple-negative breast cancer (mTNBC)(2022)
Auteurs: Kevin Punie
- Post-progression therapy outcomes in patients (pts) from the phase 3 ASCENT study of sacituzumab govitecan (SG) in metastatic triple-negative breast cancer (mTNBC)(2022)
Auteurs: Kevin Punie
- Genomics of metastatic breast cancer(2022)
Auteurs: Tatjana Geukens, Maxim De Schepper, François Richard, Sophia Leduc, Edoardo Isnaldi, Ha Linh Nguyen, Wouter Van Den Bogaert, Kevin Punie, Patrick Neven, Hans Wildiers, et al.
Pagina's: 18 - 28 - The impact of COVID-19 on oncology professionals-one year on: lessons learned from the ESMO Resilience Task Force survey series(2022)
Auteurs: Kevin Punie
- Safety of assisted reproductive techniques in young women harboring germline pathogenic variants in BRCA1/2 with a pregnancy after prior history of breast cancer(2021)
Auteurs: Kevin Punie, Lieveke Ameye
- Emerging issues related to COVID-19 vaccination in patients with cancer(2021)
Auteurs: Kevin Punie
Pagina's: 255 - 265 - Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis(2021)
Auteurs: Diether Lambrechts, Kevin Punie
- Comparison of the tumor immune microenvironment of primary hormone receptor-negative HER2-positive and triple negative breast cancer(2021)
Auteurs: Hanne Vos, Kathleen Lambein, François Richard, Ines Nevelsteen, Kevin Punie, Hans Wildiers, Lieze Berben, Annouschka Laenen, Beppe Floris, Christine Desmedt, et al.